Rh-Incompatibility-Induced Delayed Hemolytic Transfusion Reaction: Role of Immunologic Reactions in Rh-Incompatibility
Journal of Cellular & Molecular Anesthesia,
Vol. 3 No. 2 (2018),
2 September 2018
,
Page 81-85
https://doi.org/10.22037/jcma.v3i2.20884
Abstract
Blood transfusions are given to increase oxygen-carrying capacity and intravascular volume. Despite all the benefits of transfusion, it may have some complications. When mistransfusions occur, or when no other option is available, incompatible packed-cells may be infused, which puts the patient at risk of experiencing a Hemolytic Transfusion Reaction (HTR). HTRs are classified as acute or delayed reactions having wide spectrum of clinical presentations. In this report, we present a case of delayed hemolytic reaction due to Rh incompatibility in the operation room. Critical incident reporting and evaluation of adverse transfusion reactions may provide effective patient management and prevent the occurrence or repetition of these events.
- Transfusion
- hemolytic transfusion reaction
- blood group incompatibility
- antibody
How to Cite
References
Davenport RD BM. Management of transfusion reactions. 2011:757-784.
Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood. 2009;113(15):3406-3417.
Biovigilance Component, Hemovigilance Module Surveillance Protocol. 2014;2.1.3.
Tinegate H, Birchall J, Gray A, et al. Guideline on the investigation and management of acute transfusion reactions Prepared by the BCSH Blood Transfusion Task Force. British Journal of Haematology. 2012;159(2):143-153.
Fatalities Reported to FDA Following Blood Collection and Transfusion Annual Summary 2015.
Stowell SR, Winkler AM, Maier CL, et al. Initiation and regulation of complement during hemolytic transfusion reactions. Clinical & developmental immunology. 2012;2012:307093.
Pendergrast J, Willie‐Ramharack K, Sampson L, et al. The role of inflammation in intravenous immune globulin–mediated hemolysis. Transfusion. 2015;55(S2):S65-S73.
Flegel WA. Pathogenesis and mechanisms of antibody‐mediated hemolysis. Transfusion. 2015;55(S2):S47-S58.
Huber-Lang M, Sarma JV, Zetoune FS, et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nature Medicine. 2006;12:682.
Krisinger MJ, Goebeler V, Lu Z, et al. Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway. Blood. 2012;120(8):1717-1725.
Zimring JC, Spitalnik SL. Pathobiology of Transfusion Reactions. Annual Review of Pathology: Mechanisms of Disease. 2015;10(1):83-110.
Fung M GB, Hillyer CD, Westhoff CM. Technical Manual. 2014.
Strobel E. Hemolytic Transfusion Reactions. Transfusion Medicine and Hemotherapy. 2008;35(5):346-353.
Faber J-C. Worldwide overview of existing haemovigilance systems. Transfusion and Apheresis Science.31(2):99-110.
Brown JE, Smith N, Sherfy BR. Decreasing Mislabeled Laboratory Specimens Using Barcode Technology and Bedside Printers. Journal of Nursing Care Quality. 2011;26(1):13-21.
Yaddanapudi S, Yaddanapudi LN. Indications for blood and blood product transfusion. Indian Journal of Anaesthesia. 2014;58(5):538-542.
South SF, Casina TS, Li L. Exponential error reduction in pretransfusion testing with automation. Transfusion. 2012;52(8):81S-87S.
Milkins C, Berryman J, Cantwell C, et al. Guidelines for pre‐transfusion compatibility procedures in blood transfusion laboratories. Transfusion Medicine. 2013;23(1):3-35.
MacDougall. Preventing Mistransfusions: An Evaluation of Institutional Knowledge and a Response. Anesthesia & Analgesia. 2018;126(1):247-251.
Dunbar NM, Szczepiorkowski ZM. How do we utilize a transfusion safety officer? Transfusion. 2015;55(9):2064-2068.
Irani MS, Karafin MS, Ernster L. Red cell exchange to mitigate a delayed hemolytic transfusion reaction in a patient transfused with incompatible red blood cells. Journal of Clinical Apheresis. 2017;32(1):59-61.
Werch JB. Prevention of Rh sensitization in the context of trauma: Two case reports. Journal of Clinical Apheresis. 2010;25(2):70-73.
Arneja A, Salazar JE, Jiang W, et al. Interleukin-6 receptor α signaling on CD4+ T cells drives RBC alloantibody generation and T follicular helper cell differentiation in a murine model of RBC alloimmunization. The Journal of Immunology. 2017;198(1 Supplement):201.227-201.227.
- Abstract Viewed: 381 times
- PDF Downloaded: 357 times